title: Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.
abstract: Complete complement component 6 deficiency (C6Q0) is a co-dominant genetic disease presenting as increased susceptibility to invasive Neisseria meningitidis infections. Affected individuals have two affected alleles which can be homozygous or compound heterozygous for the particular gene defects they carry. This disorder has been diagnosed relatively frequently in Western Cape South Africans. Affected patients are prescribed penicillin prophylaxis. In 2004 we commenced a clinical follow-up study of 46 patients. Of these, 43 had family age-matched C6 sufficient controls. Participants were classified as either (i) well, or (ii) having a serious illness (SI) or died (D). An SI was a long-term illness that did not allow the performance of normal daily activities. Among 43 patients, 21 were well and 22 were SI/D, while among 43 matched controls, 35 were well and eight were SI/D. This difference is highly significant. Among all 46 C6Q0 patients, those who had had recurrent infection had significantly more SI/D than those who had suffered none or one infection. Thus, this work demonstrates the long-term serious outcome of repeated meningococcal disease (MD) episodes. We investigated the frequencies of four C6Q0 pathogenic mutations known to affect Cape patients (828delG, 1138delC, 821delA and 1879delG) in 2250 newborns. A total of 103 defective alleles (2·28%) and three affected C6Q0 individuals were detected. For all defects combined, 5·24 affected subjects (C6Q0) are expected among 10,000 individuals. What is still unknown is the number of C6Q0 individuals who suffer MD or other infectious diseases.
authors.affiliation: Department of Infection, Immunity and Biochemistry, Cardiff University, Cardiff, UK. orrena@cardiff.ac.uk
authors.forename: A
authors.initials: A
authors.lastname: Orren
authors.forename: E P
authors.initials: EP
authors.lastname: Owen
authors.forename: H E
authors.initials: HE
authors.lastname: Henderson
authors.forename: L
authors.initials: L
authors.lastname: van der Merwe
authors.forename: F
authors.initials: F
authors.lastname: Leisegang
authors.forename: C
authors.initials: C
authors.lastname: Stassen
authors.forename: P C
authors.initials: PC
authors.lastname: Potter
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D003183:Complement C6 / Q000172:deficiency* / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008585:Meningitis, Meningococcal / Q000209:etiology / Q000235:genetics / Q000276:immunology; D008589:Meningococcal Infections / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D008875:Middle Aged; D009154:Mutation; D012008:Recurrence; D013019:South Africa; D055815:Young Adult
chemical_list: D003183:Complement C6